Beck Bode, LLC: AXP position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Beck Bode, LLC on AXP, newest first. How the timeline and the estimate are built.
Beck Bode, LLC held 0 AXP shares at 2026-03-31 per its 13F-HR filed 2026-05-07.
the latest 13F is the newest step
- period ended2026-03-3113F 0 sharesChange vs previous 13F -18,529 shares
13F-HR 0001420506-26-000825 filed by Beck Bode, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2025-12-3113F 18,529 sharesChange vs previous 13F -658 shares
1.14% of the 13F portfolio, value $6,854,740.
13F-HR 0001420506-26-000204 filed by Beck Bode, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 19,187 sharesChange vs previous 13F +29 shares
1.03% of the 13F portfolio, value $6,373,081.
13F-HR 0001420506-25-003434 filed by Beck Bode, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 19,158 sharesChange vs previous 13F +19,158 shares
1.03% of the 13F portfolio, value $6,111,178.
13F-HR 0001420506-25-001775 filed by Beck Bode, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 0 sharesChange vs previous 13F -1,940 shares
13F-HR 0001420506-25-000455 filed by Beck Bode, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2024-09-3013F 1,940 sharesChange vs previous 13F not available
0.1% of the 13F portfolio, value $526,023.
13F-HR 0001420506-24-002269 filed by Beck Bode, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).